Search results
Axsome (AXSM) Down on Public Offering of Common Stock
Zacks via Yahoo Finance· 11 months agoAxsome AXSM announced that it is floating a secondary issue of 3 million shares of its common stock...
Axsome (AXSM) Soars 8.1%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 11 months agoAxsome (AXSM) was a big mover last session on higher-than-average trading volume. The latest trend...
Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
Zacks via Yahoo Finance· 1 week agoAxsome Therapeutics, Inc. AXSM reported an adjusted loss of $1.00 per share for the first quarter of...
Axsome (AXSM) Upgraded to Strong Buy: Here's What You Should Know
Zacks via Yahoo Finance· 10 months agoAxsome (AXSM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about...
Axsome (AXSM) Hurt by Regulatory Setbacks: Will It Recover?
Zacks via Yahoo Finance· 2 years agoAxsome's (AXSM) extension of the review period for AXS-05 NDA and CRL for AXS-07 NDA hurt prospects....
Axsome Therapeutics (AXSM) Gains But Lags Market: What You Should Know
Zacks via Yahoo Finance· 2 years agoAxsome Therapeutics (AXSM) closed at $45.33 in the latest trading session, marking a +1.59% move...
Highly Rated Axsome Surges On Earnings Beat. And Here's Why BioXcel Reversed.
Investor's Business Daily· 1 year agoAxsome Therapeutics and BioXcel Therapeutics issued divergent earnings reports Monday. BTAI stock...
Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges
Investor's Business Daily· 2 years agoRelmada Therapeutics stock crashed Thursday after its depression treatment failed a final-phase...
Analysts Are Updating Their Axsome Therapeutics, Inc. (NASDAQ:AXSM) Estimates After Its...
Simply Wall St. via Yahoo Finance· 2 years agoShareholders of Axsome Therapeutics, Inc. (NASDAQ:AXSM) will be pleased this week, given that the...
Axsome (AXSM) Focuses on Auvelity Launch to Fuel Its Growth
Zacks via Yahoo Finance· 1 year agoAxsome Therapeutics AXSM is progressing well with the launch of its first product, Auvelity...